New Key Statistics Module, Z-Score and F-Score
OTCPK:EMMA Key Ratios
| Market Cap $ M | 4.55 |
| Enterprise Value $ M | 32.26 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.33 |
| Price/Free Cash Flow | 1.33 |
| Price/Owner Earnings | 10.81 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 15.00 |
| EPS (TTM) $ | -0.09 |
| Beneish M-Score | -5.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -24.00 |
| EV-to-EBIT | 12.92 |
| EV-to-EBITDA | 12.62 |
| PEG | -- |
| Shares Outstanding M | 70.19 |
| Net Margin (%) | -38.78 |
| Operating Margin % | 29.29 |
| Pre-tax Margin (%) | -34.93 |
| Quick Ratio | 0.07 |
| Current Ratio | 0.09 |
| ROA % (ttm) | -29.93 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | 7.81 |
| Dividend Yield % | -- |
| Altman Z-Score | -26.19 |
EMMA Number of Guru Trades
EMMA Volume of Guru Trades
Gurus Latest Trades with OTCPK:EMMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:EMMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Emmaus Life Sciences Inc Insider Transactions
No Available Data
News about OTCPK:EMMA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers